Phillips & Cohen In The Media

Sean McKessy in Ignites, 1/25/17. The case serves as a “cautionary tale” for other firms that “the SEC really doesn’t like when companies target their programs,” says Sean...

Sean McKessy in the National Law Journal, 1/6/17. Sean McKessy, who stepped down in July as the whistleblower office’s first chief, said Friday’s award marks the second time the SEC has deemed...

Article by Erika Kelton published in the NYU Compliance & Enforcement Blog, 01/05/17. “2016 was a banner year for the Dodd-Frank Act’s most significant anti-fraud enforcement provisions: the...

Sean McKessy in BNA Securities Law Daily, 12/23/16. “[Phillips & Cohen partner Sean McKessy] took what he knew from previous SEC and corporate experience and dived right into the whistle-blower...

Sean McKessy in The Mercury News, 12/16/16. Q: Tech firms maintain a lot of secrecy around their work – does that affect people’s willingness to blow the whistle to the SEC? [McKessy]: There...

Letter to the Editor by Erika Kelton published in The New York Times, 12/3/16. “Gretchen Morgenson’s column “A Win for a Whistle-Blower” (Fair Game, Nov. 27) captures the retaliation that employees...

Sean McKessy in TechCrunch, 11/18/16. “…There’s a temptation here to make yourself look more valuable than you are to attract investors. So I think all that makes Silicon Valley fertile...

Sean McKessy in The National Law Journal, 11/16/16. “What will be interesting to see is whether the enforcement staff has the brakes pulled on them a bit,” said Phillips & Cohen partner...

Erika Kelton in The Mercury News, 11/4/16. “The FDA rules and regulations for marketing a prescription drug or device are there for a very good reason: to protect the public,” said Erika Kelton, a...

Sean McKessy in Ignites (Financial Times), 11/1/16. The SEC’s recent amicus brief is the second that it has filed in the case on the issue of whistle-blower status. The agency also filed an amicus brief...